Viewing Study NCT04714593


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-04-19 @ 7:56 PM
Study NCT ID: NCT04714593
Status: UNKNOWN
Last Update Posted: 2021-01-22
First Post: 2021-01-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia
Sponsor: Shanxi Province Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module